This report provides comprehensive information on the current therapeutic developmental pipeline of AlgiPharma ASs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides brief overview of AlgiPharma AS including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of AlgiPharma ASs human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AlgiPharma ASs pipeline products Reasons to buy Evaluate AlgiPharma ASs strategic position with total access to detailed information on its product pipeline Assess the growth potential of AlgiPharma AS in its therapy areas of focus Identify new drug targets and therapeutic classes in the AlgiPharma ASs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of AlgiPharma AS and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain c

1. AlgiPharma AS - Product Pipeline Review - 2015
Global Markets Directs, AlgiPharma AS Product Pipeline Review 2015, provides an overview of the AlgiPharma ASs pharmaceutical research and development
focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of AlgiPharma ASs, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of AlgiPharma AS including business description, key information and facts, and its locations and subsidiaries The report
reviews current pipeline of AlgiPharma ASs human therapeutic division and enlists all their major and minor projects The report features product description and
descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed
and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals
relating to the AlgiPharma ASs pipeline products Reasons to buy
Evaluate AlgiPharma ASs strategic position with total access to detailed information on its product pipeline Assess the growth potential of AlgiPharma AS in
its therapy areas of focus Identify new drug targets and therapeutic classes in the AlgiPharma ASs R&D portfolio and develop key strategic initiatives to reinforce
pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by
understanding the focus areas of AlgiPharma AS and exploit collaboration and partnership opportunities Identify emerging players with potentially strong
product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most
promising pipeline of AlgiPharma AS Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive
projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of AlgiPharma AS and identify potential
opportunities in those areas Avoid Intellectual Property Rights related issues
table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
algipharma As Snapshot 4
algipharma As Overview 4
key Information 4
key Facts 4
algipharma As - Research And Development Overview 5
key Therapeutic Areas 5
algipharma As - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
algipharma As - Pipeline Products Glance 9
algipharma As - Clinical Stage Pipeline Products 9
phase Ii Products/combination Treatment Modalities 9
phase I Products/combination Treatment Modalities 10
algipharma As - Early Stage Pipeline Products 11
preclinical Products/combination Treatment Modalities 11
algipharma As - Unknown Stage Pipeline Products 12
unknown Products/combination Treatment Modalities 12
algipharma As - Drug Profiles 13
oligomer G For Cystic Fibrosis 13
product Description 13
mechanism Of Action 13
r&d Progress 13
oligomer G For Copd 15
product Description 15
mechanism Of Action 15
r&d Progress 15
oligomer G For Wounds And Burns 16
product Description 16
mechanism Of Action 16
r&d Progress 16
AlgiPharma AS - Product Pipeline Review - 2015

2. oligomer G For Pseudomonas Aeruginosa Infectious 17
product Description 17
mechanism Of Action 17
r&d Progress 17
algipharma As - Pipeline Analysis 18
algipharma As - Pipeline Products By Route Of Administration 18
algipharma As - Pipeline Products By Molecule Type 19
algipharma As - Recent Pipeline Updates 20
algipharma As - Locations And Subsidiaries 21
head Office 21
appendix 22
methodology 22
coverage 22
secondary Research 22
primary Research 22
expert Panel Validation 22
contact Us 22
disclaimer 23
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
AlgiPharma AS - Product Pipeline Review - 2015